Gianluca Del Conte

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

Kim N., Dana E. Rathkopf, Matthew R. Smith et al. · Journal of Clinical Oncology · 2023 · 319 citations · Full text

Medicine, Oncology, Urology +17

Phase I study of olaparib in combination with liposomal doxorubicin in patients with advanced solid tumours

Gianluca Del Conte, Cristiana Sessa, Roger von Moos et al. · British Journal of Cancer · 2014 · 103 citations · Full text

Medicine, Oncology, Pharmacology +17

A Multi-Arm Phase I Study of the PI3K/mTOR Inhibitors PF-04691502 and Gedatolisib (PF-05212384) plus Irinotecan or the MEK Inhibitor PD-0325901 in Advanced Cancer

Zev A. Wainberg, María Alsina, Heloisa P. Soares et al. · Targeted Oncology · 2017 · 95 citations · Full text

Medicine, Oncology, Pharmacology +16

A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancer

Stan B. Kaye, Christopher Poole, Anna Dańska-Bidzińska et al. · Annals of Oncology · 2012 · 91 citations · Full text

Medicine, Gynecology, Oncology +17

Patient Selection for Oncology Phase I Trials: A Multi-Institutional Study of Prognostic Factors

David Olmos, Roger A’Hern, Silvia Marsoni et al. · Journal of Clinical Oncology · 2012 · 81 citations · Full text

Medicine, Oncology, Clinical Decision Support +16